摘要
糖尿病是以高血糖为特征的代谢性疾病,经统计发现糖尿病患者中腹主动脉瘤(AAA)的发病率和病死率较非糖尿病人群偏低。本文将论述糖尿病及其治疗对主动脉瘤疾病进程的保护作用,为AAA的临床治疗提供更多支持。
Diabetes mellitus is a metabolic disease characterized by hyperglycemia.It is found that the incidence and mortality of abdominal aortic aneurysm(AAA)in diabetes mellitus patients are lower than that in non-diabetes mellitus patients.This review will present the protective role of diabetes mellitus and its treatment on the aortic disease process,aiming to provide more support for the clinical treatment of AAA.
作者
王洪亚
陈兵
刘震杰
Wang Hongya;Chen Bing;Liu Zhenjie(Department of Vascular Surgery,the Second Affiliated Hospital of Zhejiang University,Hangzhou 310052,China)
出处
《国际外科学杂志》
2022年第11期776-780,共5页
International Journal of Surgery
关键词
糖尿病
细胞外基质
腹主动脉瘤
治疗应用
抗糖尿病药物
钠-葡萄糖协同转运体蛋白2
Diabetes mellitus
Extracellular matrix
Therapeutic uses
Abdominal aneurysm
Anti-diabetic drugs
Sodium-dependent glucose transporters 2